Your browser is no longer supported. Please, upgrade your browser.
NVO Novo Nordisk A/S daily Stock Chart
Novo Nordisk A/S
Index- P/E22.53 EPS (ttm)2.33 Insider Own26.40% Shs Outstand1.87B Perf Week2.52%
Market Cap98.17B Forward P/E18.93 EPS next Y2.78 Insider Trans0.00% Shs Float1.23B Perf Month1.23%
Income5.59B PEG2.11 EPS next Q0.61 Inst Own9.80% Short Float0.53% Perf Quarter8.51%
Sales17.40B P/S5.64 EPS this Y3.50% Inst Trans-0.04% Short Ratio4.45 Perf Half Y9.19%
Book/sh3.32 P/B15.82 EPS next Y15.77% ROA34.10% Target Price57.90 Perf Year20.74%
Cash/sh- P/C- EPS next 5Y10.70% ROE75.20% 52W Range41.59 - 53.55 Perf YTD14.00%
Dividend1.25 P/FCF44.38 EPS past 5Y11.30% ROI73.10% 52W High-1.92% Beta0.60
Dividend %2.38% Quick Ratio0.70 Sales past 5Y6.00% Gross Margin84.00% 52W Low26.28% ATR0.78
Employees41611 Current Ratio1.00 Sales Q/Q9.60% Oper. Margin43.00% RSI (14)56.29 Volatility0.89% 1.20%
OptionableYes Debt/Eq0.08 EPS Q/Q-5.40% Profit Margin32.20% Rel Volume0.53 Prev Close52.68
ShortableYes LT Debt/Eq0.06 EarningsOct 31 BMO Payout347.30% Avg Volume1.46M Price52.52
Recom3.00 SMA201.35% SMA501.86% SMA2005.35% Volume776,759 Change-0.30%
Sep-17-19Upgrade Citigroup Neutral → Buy
Aug-30-19Downgrade Jefferies Hold → Underperform
Jun-20-19Downgrade Deutsche Bank Buy → Hold
Jun-11-19Upgrade Barclays Underweight → Equal Weight
Apr-29-19Upgrade Credit Suisse Neutral → Outperform
Jan-29-19Initiated Exane BNP Paribas Outperform
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Dec-29-17Upgrade JP Morgan Underweight → Neutral
Dec-06-17Upgrade BofA/Merrill Neutral → Buy
Dec-01-17Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-25-17Downgrade Exane BNP Paribas Outperform → Neutral
Sep-06-17Upgrade BofA/Merrill Underperform → Neutral
Oct-31-16Downgrade DNB Markets Buy → Hold
Oct-31-16Downgrade Citigroup Buy → Neutral
Oct-28-16Downgrade BofA/Merrill Neutral → Underperform
Sep-23-16Initiated Piper Jaffray Neutral
Sep-13-16Upgrade Exane BNP Paribas Neutral → Outperform
Sep-09-16Downgrade JP Morgan Overweight → Neutral
Sep-01-16Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-17-19 09:30AM  PFE vs. NVO: Which Stock Is the Better Value Option? Zacks
Oct-16-19 11:14AM  The Zacks Analyst Blog Highlights: Intel, Oracle, Novo Nordisk, ConocoPhillips and Advanced Micro Devices Zacks
Oct-15-19 12:59PM  Top Analyst Reports for Intel, Oracle & Novo Nordisk Zacks
Oct-14-19 10:15AM  The Zacks Analyst Blog Highlights: Novartis, J&J, Pfizer, Novo Nordisk and Glaxo Zacks
Oct-13-19 05:15PM  New Sanofi CEO Looks to Shake Things Up
Oct-11-19 11:03AM  Pharma Stock Roundup: NVS' New Eye Drug Gets FDA Nod, NVO, GSK, PFE Sign Deals Zacks
09:19AM  Gilead-Galapagos Report Efficacy & Safety Results on RA Drug Zacks
Oct-10-19 11:17AM  bluebird Inks Genome Editing Research Deal With Novo Nordisk Zacks
Oct-09-19 08:12PM  Is Novo Nordisk A/S (NVO) A Good Stock To Buy? Insider Monkey
05:33PM  5 European Health Care Companies With High Business Quality
Oct-07-19 09:08AM  Novo Nordisk Focuses on Pipeline Development Amid Competition Zacks
Oct-04-19 10:45AM  Gilead's Descovy HIV Regimen Gets FDA Nod for Label Expansion Zacks
Oct-01-19 12:51AM  An Intrinsic Calculation For Novo Nordisk A/S (CPH:NOVO B) Suggests It's 25% Undervalued Simply Wall St.
12:00AM  Insulin maker Novo Nordisk walks moral tightrope Financial Times
Sep-27-19 05:54PM  4 High-Quality US Stocks as Trade War Fears Are Rekindled
03:42PM  Cool Chain Association Calls For Data Sharing Benzinga
09:40AM  SNY or NVO: Which Is the Better Value Stock Right Now? Zacks
Sep-26-19 12:38PM  Foreign Firms Recognized as Hottest Biotechs
11:40AM  Enanta's Stock Down Despite NASH Drug Meeting Goal in Study Zacks
Sep-25-19 12:37AM  Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023 Moody's
12:00AM  Loyalty shares can promote better long-term stewardship Financial Times
Sep-24-19 04:40PM  Novo Nordisk A/S -- Moody's announces completion of a periodic review of ratings of Novo Nordisk A/S Moody's
04:17PM  How Novo Nordisk Is Aiming To Take A Slice Of Lilly's Diabetes Market Investor's Business Daily
11:46AM  Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023 Moody's
Sep-23-19 12:42PM  Novo Nordisk's Semaglutide in Tablet Form Gets FDA Approval Zacks
10:32AM  Lilly Gets CHMP Nod to Add Heart Indication to Trulicity Label Zacks
07:31AM  Novo Nordisk targets bigger slice of diabetes market with new tablet Reuters
Sep-20-19 11:24AM  UPDATE 2-Novo Nordisk wins U.S. approval for first-of-its-kind oral diabetes drug Reuters
04:43AM  UPDATE 2-European shares log fifth week of gains, Novo Nordisk shines Reuters
Sep-17-19 04:37PM  How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal Investor's Business Daily
09:46AM  Why this diabetes patient fears a no-deal Brexit Reuters Videos
03:42AM  Factbox: Britain's insulin providers prepare for Brexit fallout Reuters
03:41AM  With a backup to the backup, insulin makers say they're primed for Brexit Reuters
03:09AM  With a backup to the backup, insulin makers say they're primed for Brexit Reuters
Sep-15-19 11:18AM  The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck Benzinga
Sep-12-19 01:55PM  5 Companies Growing Earnings
Sep-10-19 05:37PM  5 Companies With High Predictability
08:05AM  New international study: The hidden burden of diabetes on family members revealed CNW Group
Sep-06-19 09:14AM  UPDATE 1-Novo Nordisk to cut insulin prices in the U.S. Reuters
08:22AM  Novo Nordisk to cut insulin prices in the U.S. Reuters
07:00AM  2 Stocks to Watch in September Motley Fool
Sep-04-19 10:32AM  Vertex (VRTX) Inks All-Cash Deal to Acquire Semma for $950M Zacks
Sep-02-19 05:50AM  We Think Novo Nordisk (CPH:NOVO B) Can Stay On Top Of Its Debt Simply Wall St.
Aug-29-19 02:36PM  Drugmaker's $27 million gift will have 'big impact' on NC State American City Business Journals
Aug-28-19 04:13PM  J&J (JNJ) Loses Landmark Opioid Case: What's Next for Pharmaceuticals? Zacks
08:02AM  Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates Benzinga
Aug-26-19 08:28AM  Gilead & Galapagos Close Research & Development Agreement Zacks
Aug-23-19 10:00AM  Novo Nordisk (NVO) Is Up 2.77% in One Week: What You Should Know Zacks
Aug-22-19 02:39PM  Novo Nordisk Suing Mylan Over Generic Victoza Drug InvestorPlace
02:37PM  Novo Nordisk's Fiasp Gets EC Approval for Label Expansion Zacks
03:09AM  Denmark's Novo Nordisk files lawsuit against Mylan over patent Reuters
Aug-19-19 06:40PM  5 Dividend Growth Stocks to Consider in Light of Falling Treasury Yields
11:15AM  The Zacks Analyst Blog Highlights: Cisco, Medtronic, Novo Nordisk, Southern and TransDigm Zacks
Aug-16-19 02:33PM  Top Stock Reports for Cisco, Medtronic & Novo Nordisk Zacks
09:15AM  UPDATE 2-Novo Nordisk contests Danish lawsuit claiming $1.75 bln Reuters
07:29AM  Novo Nordisk sued in Denmark for alleged market manipulation - media Reuters
Aug-15-19 04:45PM  Novo Nordisk Waits for Its Next Launch Motley Fool
Aug-14-19 01:00PM  Calling life science innovators: don't miss your chance for a "Golden Ticket" to LabCentral PR Newswire
Aug-13-19 06:00AM  How one Boston startup rode the diabetes investment wave to raise $126M American City Business Journals
Aug-12-19 08:35AM  Why Earnings Season Could Be Great for Novo Nordisk (NVO) Zacks
Aug-11-19 11:19PM  Will These 3 Good Performers Beat the Market?
Aug-09-19 09:50AM  Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients Zacks
09:34AM  Novo Nordisk's new diabetes, obesity drugs lift sales outlook Reuters
09:27AM  Novo Nordisk (NVO) Q2 Earnings & Revenues Beat Estimates Zacks
Aug-08-19 09:30AM  NVS vs. NVO: Which Stock Should Value Investors Buy Now? Zacks
05:09AM  If You Had Bought Novo Nordisk (CPH:NOVO B) Stock Five Years Ago, You Could Pocket A 32% Gain Today Simply Wall St.
Aug-06-19 06:51AM  Diabetes drug maker Novo Nordisk buys pill factory in North Carolina Reuters
Jul-15-19 08:59AM  Gilead-Galapagos Ink $5.1B Deal for Additional Compounds Zacks
Jul-14-19 11:10AM  Health companies start reporting earnings next week: Here are 3 things to keep in mind MarketWatch
Jul-12-19 08:36AM  Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY Zacks
07:16AM  Sunnova Energy to offer 17.6 million shares in IPO, priced at $16 to $18 each MarketWatch
Jul-10-19 11:24AM  Court Ruling Topples Trump Order, No Price Display in TV Ads Zacks
Jul-09-19 06:01PM  Novo Nordisk Reports Encouraging Data From Hemophilia Studies Zacks
12:12AM  Would Novo Nordisk A/S (CPH:NOVO B) Be Valuable To Income Investors? Simply Wall St.
Jul-05-19 08:09PM  The Top 10 Biotechnology Companies (JNJ, ROG.VX) Investopedia
Jul-01-19 07:00AM  Market Morning: OPEC Cuts, Trump & Xi Ceasefire, Apple Goes to China, Deutsche Bank Hiring Market Exclusive
Jun-29-19 09:57PM  How Adobe Inc and Other Hedge Fund Favorites Performed in Q2 Insider Monkey
08:25AM  The Week Ahead In Biotech: Pending Clinical Readouts In Focus Benzinga
Jun-27-19 10:54AM  Lilly's Study on Higher Doses of Trulicity Meets Endpoint Zacks
Jun-26-19 06:24AM  Gilead Inks Deal With Carna Biosciences for Immuno-Oncology Zacks
Jun-25-19 11:02AM  The 10 Biggest Biotech Stocks Motley Fool
Jun-21-19 05:36PM  Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval Zacks
09:07AM  Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod Zacks
Jun-20-19 06:33AM  Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs Zacks
Jun-19-19 09:30AM  NVS or NVO: Which Is the Better Value Stock Right Now? Zacks
Jun-18-19 09:18AM  Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients Zacks
07:31AM  The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale Benzinga
07:09AM  Shares of cancer-therapy companies skyrocket after Pfizer acquisition news MarketWatch
Jun-17-19 04:01PM  FDA approves non-insulin Type 2 diabetes drug for kids, the first to hit market in 20 years MarketWatch
Jun-14-19 08:42AM  Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod Zacks
Jun-13-19 04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
Jun-12-19 07:01PM  Jim Cramer: A Tale of Two Stocks
12:11PM  Why This Dow Jones Pharmaceutical Giant Is Trying To Break Out Investor's Business Daily
03:36AM  What Should Investors Know About Novo Nordisk A/S's (CPH:NOVO B) Growth? Simply Wall St.
Jun-11-19 02:45PM  This Pharma Wants To Scoop Its Rivals With An Oral Diabetes Med Investor's Business Daily
02:45PM  CORRECTED-Oral Novo Nordisk diabetes drug poses no more heart risk than placebo -study Reuters
04:30AM  UPDATE 2-China stimulus, German rally help European stock end higher Reuters
Jun-10-19 09:06AM  Eli Lilly Stock Is Falling and Novo Nordisk Is Rising on Diabetes-Drug Results
May-29-19 09:30AM  BMY or NVO: Which Is the Better Value Stock Right Now? Zacks
May-28-19 04:02PM  Gilead Gains 6.8% YTD as HIV Franchise Maintains Momentum Zacks
Novo Nordisk A/S, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Biopharmaceuticals. The Diabetes Care and Obesity segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral anti-diabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company has a strategic alliance with Evotec AG to discover and develop small molecule therapies to treat patients suffering from diabetes, obesity, and co-morbidities, as well as has a research collaboration with Kallyope Inc. It also has collaboration agreements with Lund University to develop stem cell-derived treatment for Parkinson's diseases; Staten Biotechnology B.V. to develop novel therapeutics for the treatment of dyslipidaemia; Medtronic plc to develop integrated digital solutions for people with diabetes; and bluebird bio, Inc. to develop in vivo genome editing treatments for genetic diseases. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.